510(k) K251854

SteadiSet infusion set by Tandem Diabetes Care — Product Code FPA

K251854 is an FDA 510(k) premarket notification submitted by Tandem Diabetes Care for the device "SteadiSet infusion set". The FDA issued a decision of Substantially Equivalent on August 6, 2025. The device falls under product code FPA (Set, Administration, Intravascular), a Class II device regulated under 21 CFR 880.5440. Tandem Diabetes Care has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 6, 2025
Date Received
June 17, 2025
Clearance Type
Abbreviated
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Set, Administration, Intravascular
Device Class
Class II
Regulation Number
880.5440
Review Panel
HO
Submission Type